Share Price and Basic Stock Data
Last Updated: January 3, 2026, 11:34 am
| PEG Ratio | 2.38 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Insecticides India Ltd, operating in the agrochemicals sector, reported a market capitalization of ₹2,064 Cr and a share price of ₹710. The company has demonstrated a steady revenue trajectory with sales recorded at ₹1,801 Cr for the fiscal year ending March 2023, marking an increase from ₹1,504 Cr in March 2022. This upward trend continued into the trailing twelve months (TTM), where sales rose to ₹2,051 Cr. Quarterly sales figures have shown fluctuations, with the highest quarterly sales of ₹696 Cr reported in September 2023, indicating resilience in demand. The company’s operating profit margin (OPM) stood at 11.41% for the fiscal year ending March 2025. However, quarterly OPMs reveal variability, with a notable peak of 14% in September 2024, suggesting potential for improved operational efficiency in favorable market conditions. These trends highlight the company’s capacity to navigate market dynamics while maintaining revenue growth.
Profitability and Efficiency Metrics
Insecticides India Ltd’s profitability metrics illustrate a solid performance, with a net profit of ₹142 Cr reported for the fiscal year ending March 2025, up from ₹107 Cr in March 2022. The company achieved an impressive return on equity (ROE) of 13.3% and a return on capital employed (ROCE) of 17.2%, indicating effective utilization of shareholder equity and capital. Operating profit for the fiscal year 2025 rose to ₹219 Cr, reflecting a significant improvement from ₹171 Cr in 2022. Despite some quarterly challenges, such as a negative operating profit of ₹28 Cr in March 2023, the company rebounded with a profit of ₹85 Cr in September 2025. Efficiency ratios also indicate a strong operational framework, with the interest coverage ratio (ICR) at 33.25x, showcasing the company’s ability to meet interest obligations comfortably. This level of profitability and operational efficiency positions Insecticides India favorably compared to typical sector averages.
Balance Sheet Strength and Financial Ratios
The balance sheet of Insecticides India Ltd reflects a robust financial position. As of March 2025, total assets were reported at ₹1,888 Cr, with total liabilities at ₹1,888 Cr, indicating a balanced financial structure. The company’s reserves have steadily increased, reaching ₹1,167 Cr by September 2025, while borrowings stood at ₹242 Cr, demonstrating prudent financial management. The debt-to-equity ratio remains low at 0.09, suggesting minimal reliance on external debt. Furthermore, the current ratio of 1.83 and a quick ratio of 0.69 indicate adequate liquidity to cover short-term obligations. The price-to-book value ratio is reported at 1.59, suggesting the stock is reasonably valued in relation to its net asset value. Overall, these financial ratios reflect a strong balance sheet that supports future growth initiatives while maintaining financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Insecticides India Ltd indicates a stable investor base, with promoters holding 72.30% of the equity as of September 2025. This significant promoter stake underscores strong insider confidence in the company’s prospects. Foreign institutional investors (FIIs) hold a modest 4.51%, while domestic institutional investors (DIIs) account for 9.50%. The public shareholding stands at 13.69%, reflecting a healthy distribution among retail investors. Notably, the number of shareholders has increased to 22,336 by September 2025, compared to 19,189 in December 2022, indicating growing investor interest. This stability in shareholding, combined with increasing retail participation, can be viewed as a positive signal of confidence in the company’s long-term growth potential. However, the decline in FII participation from 6.27% in December 2022 to 4.51% in September 2025 may warrant attention as it could indicate shifting investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, Insecticides India Ltd is positioned for continued growth, bolstered by strong financial metrics and a solid market presence. However, risks remain, including potential fluctuations in raw material prices and regulatory challenges in the agrochemical sector. The company’s ability to maintain its profitability amidst these challenges will be critical. Additionally, the variability in quarterly sales and operating profits suggests that market dynamics can significantly impact financial performance. To capitalize on growth opportunities, Insecticides India may need to diversify its product offerings and enhance operational efficiencies further. Overall, while the company exhibits strengths in profitability and balance sheet stability, it must navigate inherent sector risks to sustain its growth trajectory in the competitive agrochemical landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 5,375 Cr. | 1,246 | 2,114/1,213 | 13.4 | 487 | 0.48 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 829 Cr. | 245 | 391/165 | 17.0 | 131 | 0.00 % | 12.0 % | 9.28 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 63.7 Cr. | 122 | 149/56.6 | 11.4 | 40.0 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 2,601 Cr. | 201 | 331/198 | 98.2 | 54.9 | 0.07 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 923 Cr. | 390 | 620/244 | 72.1 | 342 | 0.51 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,195.70 Cr | 1,134.10 | 31.52 | 382.34 | 0.42% | 15.21% | 19.87% | 7.04 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 582 | 357 | 302 | 640 | 696 | 358 | 272 | 657 | 627 | 359 | 359 | 691 | 641 |
| Expenses | 514 | 333 | 330 | 594 | 614 | 332 | 263 | 585 | 537 | 331 | 331 | 607 | 556 |
| Operating Profit | 68 | 23 | -28 | 46 | 82 | 26 | 9 | 72 | 90 | 29 | 28 | 84 | 85 |
| OPM % | 12% | 7% | -9% | 7% | 12% | 7% | 3% | 11% | 14% | 8% | 8% | 12% | 13% |
| Other Income | 0 | 0 | 0 | 4 | -0 | 1 | 5 | 3 | 2 | 0 | 3 | 4 | 3 |
| Interest | 3 | 5 | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 2 | 4 | 4 |
| Depreciation | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 7 | 9 |
| Profit before tax | 60 | 12 | -39 | 39 | 72 | 17 | 4 | 66 | 82 | 20 | 22 | 77 | 74 |
| Tax % | 25% | 25% | -26% | 26% | 26% | 28% | -95% | 25% | 25% | 25% | 37% | 25% | 25% |
| Net Profit | 45 | 9 | -29 | 29 | 53 | 12 | 8 | 49 | 62 | 15 | 14 | 57 | 55 |
| EPS in Rs | 15.09 | 3.15 | -9.80 | 9.81 | 17.99 | 4.15 | 2.73 | 16.60 | 21.17 | 5.16 | 4.82 | 19.69 | 19.01 |
Last Updated: January 1, 2026, 6:46 am
Below is a detailed analysis of the quarterly data for Insecticides India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 641.00 Cr.. The value appears to be declining and may need further review. It has decreased from 691.00 Cr. (Jun 2025) to 641.00 Cr., marking a decrease of 50.00 Cr..
- For Expenses, as of Sep 2025, the value is 556.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 607.00 Cr. (Jun 2025) to 556.00 Cr., marking a decrease of 51.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 85.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Jun 2025) to 85.00 Cr., marking an increase of 1.00 Cr..
- For OPM %, as of Sep 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Jun 2025) to 13.00%, marking an increase of 1.00%.
- For Other Income, as of Sep 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Jun 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 4.00 Cr..
- For Depreciation, as of Sep 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.00 Cr. (Jun 2025) to 9.00 Cr., marking an increase of 2.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 74.00 Cr.. The value appears to be declining and may need further review. It has decreased from 77.00 Cr. (Jun 2025) to 74.00 Cr., marking a decrease of 3.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 25.00%.
- For Net Profit, as of Sep 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Jun 2025) to 55.00 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 19.01. The value appears to be declining and may need further review. It has decreased from 19.69 (Jun 2025) to 19.01, marking a decrease of 0.68.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:11 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 801 | 892 | 906 | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 2,002 | 2,051 |
| Expenses | 719 | 781 | 815 | 880 | 925 | 1,006 | 1,207 | 1,268 | 1,333 | 1,679 | 1,803 | 1,783 | 1,825 |
| Operating Profit | 82 | 111 | 91 | 114 | 148 | 188 | 156 | 153 | 171 | 122 | 163 | 219 | 226 |
| OPM % | 10% | 12% | 10% | 11% | 14% | 16% | 11% | 11% | 11% | 7% | 8% | 11% | 11% |
| Other Income | 0 | 0 | 0 | 4 | 3 | 0 | 2 | -2 | 3 | 1 | 10 | 7 | 10 |
| Interest | 27 | 33 | 26 | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 | 7 | 11 |
| Depreciation | 7 | 14 | 16 | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 | 29 | 31 |
| Profit before tax | 49 | 64 | 50 | 82 | 118 | 153 | 110 | 119 | 141 | 84 | 133 | 190 | 193 |
| Tax % | 18% | 15% | 21% | 28% | 29% | 20% | 22% | 22% | 24% | 25% | 23% | 27% | |
| Net Profit | 40 | 55 | 39 | 59 | 84 | 122 | 86 | 93 | 107 | 63 | 103 | 140 | 142 |
| EPS in Rs | 14.01 | 19.24 | 12.67 | 19.16 | 27.09 | 39.49 | 27.75 | 30.14 | 36.16 | 21.28 | 34.67 | 48.03 | 48.68 |
| Dividend Payout % | 10% | 0% | 11% | 7% | 5% | 3% | 10% | 4% | 6% | 14% | 9% | 4% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 37.50% | -29.09% | 51.28% | 42.37% | 45.24% | -29.51% | 8.14% | 15.05% | -41.12% | 63.49% | 35.92% |
| Change in YoY Net Profit Growth (%) | 0.00% | -66.59% | 80.37% | -8.91% | 2.87% | -74.75% | 37.65% | 6.91% | -56.18% | 104.61% | -27.57% |
Insecticides India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 8% |
| 3 Years: | 10% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 10% |
| 3 Years: | 9% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 20% |
| 3 Years: | 8% |
| 1 Year: | -15% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 11% |
| 3 Years: | 10% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 7:40 am
Balance Sheet
Last Updated: December 4, 2025, 1:26 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 30 | 30 | 29 | 29 |
| Reserves | 234 | 279 | 388 | 444 | 527 | 641 | 710 | 798 | 847 | 886 | 982 | 1,053 | 1,167 |
| Borrowings | 258 | 322 | 206 | 237 | 114 | 305 | 191 | 100 | 54 | 163 | 87 | 104 | 242 |
| Other Liabilities | 287 | 308 | 322 | 277 | 338 | 388 | 372 | 505 | 473 | 615 | 611 | 702 | 536 |
| Total Liabilities | 791 | 921 | 936 | 978 | 1,000 | 1,355 | 1,293 | 1,424 | 1,394 | 1,694 | 1,710 | 1,888 | 1,973 |
| Fixed Assets | 170 | 205 | 194 | 185 | 232 | 240 | 239 | 239 | 253 | 262 | 283 | 278 | 380 |
| CWIP | 54 | 38 | 51 | 58 | 17 | 19 | 39 | 59 | 91 | 123 | 141 | 161 | 81 |
| Investments | 11 | 11 | 11 | 11 | 16 | 12 | 10 | 12 | 13 | 15 | 19 | 26 | 29 |
| Other Assets | 556 | 667 | 680 | 725 | 735 | 1,084 | 1,004 | 1,115 | 1,037 | 1,293 | 1,267 | 1,422 | 1,483 |
| Total Assets | 791 | 921 | 936 | 978 | 1,000 | 1,355 | 1,293 | 1,424 | 1,394 | 1,694 | 1,710 | 1,888 | 1,973 |
Below is a detailed analysis of the balance sheet data for Insecticides India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 29.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 29.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,167.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,053.00 Cr. (Mar 2025) to 1,167.00 Cr., marking an increase of 114.00 Cr..
- For Borrowings, as of Sep 2025, the value is 242.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 104.00 Cr. (Mar 2025) to 242.00 Cr., marking an increase of 138.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 536.00 Cr.. The value appears to be improving (decreasing). It has decreased from 702.00 Cr. (Mar 2025) to 536.00 Cr., marking a decrease of 166.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,973.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,888.00 Cr. (Mar 2025) to 1,973.00 Cr., marking an increase of 85.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 380.00 Cr.. The value appears strong and on an upward trend. It has increased from 278.00 Cr. (Mar 2025) to 380.00 Cr., marking an increase of 102.00 Cr..
- For CWIP, as of Sep 2025, the value is 81.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2025) to 81.00 Cr., marking a decrease of 80.00 Cr..
- For Investments, as of Sep 2025, the value is 29.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 3.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,483.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,422.00 Cr. (Mar 2025) to 1,483.00 Cr., marking an increase of 61.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,973.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,888.00 Cr. (Mar 2025) to 1,973.00 Cr., marking an increase of 85.00 Cr..
Notably, the Reserves (1,167.00 Cr.) exceed the Borrowings (242.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -176.00 | -211.00 | -115.00 | -123.00 | 34.00 | -117.00 | -35.00 | 53.00 | 117.00 | -41.00 | 76.00 | 115.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 58 | 68 | 84 | 78 | 80 | 75 | 86 | 65 | 70 | 60 | 55 | 70 |
| Inventory Days | 189 | 220 | 190 | 232 | 214 | 355 | 202 | 248 | 228 | 247 | 220 | 265 |
| Days Payable | 124 | 118 | 114 | 108 | 128 | 141 | 96 | 136 | 117 | 128 | 114 | 150 |
| Cash Conversion Cycle | 124 | 170 | 159 | 201 | 166 | 289 | 192 | 177 | 181 | 178 | 161 | 185 |
| Working Capital Days | 18 | 40 | 75 | 80 | 93 | 116 | 98 | 108 | 111 | 92 | 99 | 107 |
| ROCE % | 16% | 17% | 12% | 16% | 20% | 21% | 14% | 15% | 16% | 10% | 13% | 17% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Small Cap Fund | 2,636,351 | 0.5 | 190.87 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 48.38 | 34.59 | 21.36 | 54.17 | 45.43 |
| Diluted EPS (Rs.) | 48.38 | 34.59 | 21.36 | 54.17 | 45.43 |
| Cash EPS (Rs.) | 58.63 | 44.36 | 30.10 | 67.59 | 57.14 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 372.74 | 342.44 | 310.26 | 440.71 | 396.93 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 372.74 | 342.44 | 310.26 | 440.71 | 396.93 |
| Revenue From Operations / Share (Rs.) | 687.32 | 664.37 | 608.60 | 762.20 | 687.17 |
| PBDIT / Share (Rs.) | 78.43 | 58.12 | 41.61 | 88.16 | 77.44 |
| PBIT / Share (Rs.) | 68.41 | 48.24 | 32.79 | 74.80 | 65.51 |
| PBT / Share (Rs.) | 66.05 | 44.56 | 28.24 | 71.44 | 57.59 |
| Net Profit / Share (Rs.) | 48.61 | 34.48 | 21.28 | 54.24 | 45.21 |
| NP After MI And SOA / Share (Rs.) | 48.81 | 34.59 | 21.36 | 54.44 | 45.43 |
| PBDIT Margin (%) | 11.41 | 8.74 | 6.83 | 11.56 | 11.26 |
| PBIT Margin (%) | 9.95 | 7.26 | 5.38 | 9.81 | 9.53 |
| PBT Margin (%) | 9.60 | 6.70 | 4.64 | 9.37 | 8.38 |
| Net Profit Margin (%) | 7.07 | 5.18 | 3.49 | 7.11 | 6.57 |
| NP After MI And SOA Margin (%) | 7.10 | 5.20 | 3.50 | 7.14 | 6.61 |
| Return on Networth / Equity (%) | 13.09 | 10.09 | 6.88 | 12.35 | 11.44 |
| Return on Capital Employeed (%) | 17.76 | 13.50 | 10.35 | 16.61 | 16.09 |
| Return On Assets (%) | 7.48 | 5.97 | 3.72 | 7.69 | 6.58 |
| Long Term Debt / Equity (X) | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.09 | 0.08 | 0.17 | 0.05 | 0.11 |
| Asset Turnover Ratio (%) | 1.11 | 1.15 | 1.16 | 1.07 | 1.04 |
| Current Ratio (X) | 1.83 | 1.90 | 1.62 | 1.97 | 1.86 |
| Quick Ratio (X) | 0.69 | 0.67 | 0.48 | 0.73 | 0.72 |
| Inventory Turnover Ratio (X) | 2.36 | 1.60 | 1.88 | 1.61 | 1.77 |
| Dividend Payout Ratio (NP) (%) | 4.16 | 8.67 | 23.41 | 0.00 | 4.40 |
| Dividend Payout Ratio (CP) (%) | 3.45 | 6.74 | 16.56 | 0.00 | 3.48 |
| Earning Retention Ratio (%) | 95.84 | 91.33 | 76.59 | 0.00 | 95.60 |
| Cash Earning Retention Ratio (%) | 96.55 | 93.26 | 83.44 | 0.00 | 96.52 |
| Interest Coverage Ratio (X) | 33.25 | 15.80 | 9.16 | 26.22 | 24.06 |
| Interest Coverage Ratio (Post Tax) (X) | 21.61 | 10.37 | 5.68 | 17.13 | 16.51 |
| Enterprise Value (Cr.) | 1764.96 | 1468.53 | 1522.18 | 1224.20 | 990.06 |
| EV / Net Operating Revenue (X) | 0.88 | 0.74 | 0.84 | 0.81 | 0.69 |
| EV / EBITDA (X) | 7.73 | 8.54 | 12.36 | 7.04 | 6.19 |
| MarketCap / Net Operating Revenue (X) | 0.86 | 0.73 | 0.76 | 0.80 | 0.68 |
| Retention Ratios (%) | 95.83 | 91.32 | 76.58 | 0.00 | 95.59 |
| Price / BV (X) | 1.59 | 1.43 | 1.51 | 1.39 | 1.19 |
| Price / Net Operating Revenue (X) | 0.86 | 0.73 | 0.76 | 0.80 | 0.68 |
| EarningsYield | 0.08 | 0.07 | 0.04 | 0.08 | 0.09 |
After reviewing the key financial ratios for Insecticides India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 48.38. This value is within the healthy range. It has increased from 34.59 (Mar 24) to 48.38, marking an increase of 13.79.
- For Diluted EPS (Rs.), as of Mar 25, the value is 48.38. This value is within the healthy range. It has increased from 34.59 (Mar 24) to 48.38, marking an increase of 13.79.
- For Cash EPS (Rs.), as of Mar 25, the value is 58.63. This value is within the healthy range. It has increased from 44.36 (Mar 24) to 58.63, marking an increase of 14.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 372.74. It has increased from 342.44 (Mar 24) to 372.74, marking an increase of 30.30.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 372.74. It has increased from 342.44 (Mar 24) to 372.74, marking an increase of 30.30.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 687.32. It has increased from 664.37 (Mar 24) to 687.32, marking an increase of 22.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 78.43. This value is within the healthy range. It has increased from 58.12 (Mar 24) to 78.43, marking an increase of 20.31.
- For PBIT / Share (Rs.), as of Mar 25, the value is 68.41. This value is within the healthy range. It has increased from 48.24 (Mar 24) to 68.41, marking an increase of 20.17.
- For PBT / Share (Rs.), as of Mar 25, the value is 66.05. This value is within the healthy range. It has increased from 44.56 (Mar 24) to 66.05, marking an increase of 21.49.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 48.61. This value is within the healthy range. It has increased from 34.48 (Mar 24) to 48.61, marking an increase of 14.13.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 48.81. This value is within the healthy range. It has increased from 34.59 (Mar 24) to 48.81, marking an increase of 14.22.
- For PBDIT Margin (%), as of Mar 25, the value is 11.41. This value is within the healthy range. It has increased from 8.74 (Mar 24) to 11.41, marking an increase of 2.67.
- For PBIT Margin (%), as of Mar 25, the value is 9.95. This value is below the healthy minimum of 10. It has increased from 7.26 (Mar 24) to 9.95, marking an increase of 2.69.
- For PBT Margin (%), as of Mar 25, the value is 9.60. This value is below the healthy minimum of 10. It has increased from 6.70 (Mar 24) to 9.60, marking an increase of 2.90.
- For Net Profit Margin (%), as of Mar 25, the value is 7.07. This value is within the healthy range. It has increased from 5.18 (Mar 24) to 7.07, marking an increase of 1.89.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.10. This value is below the healthy minimum of 8. It has increased from 5.20 (Mar 24) to 7.10, marking an increase of 1.90.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.09. This value is below the healthy minimum of 15. It has increased from 10.09 (Mar 24) to 13.09, marking an increase of 3.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.76. This value is within the healthy range. It has increased from 13.50 (Mar 24) to 17.76, marking an increase of 4.26.
- For Return On Assets (%), as of Mar 25, the value is 7.48. This value is within the healthy range. It has increased from 5.97 (Mar 24) to 7.48, marking an increase of 1.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.09. This value is within the healthy range. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.11. It has decreased from 1.15 (Mar 24) to 1.11, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 1.90 (Mar 24) to 1.83, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.69, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 4. It has increased from 1.60 (Mar 24) to 2.36, marking an increase of 0.76.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.16. This value is below the healthy minimum of 20. It has decreased from 8.67 (Mar 24) to 4.16, marking a decrease of 4.51.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3.45. This value is below the healthy minimum of 20. It has decreased from 6.74 (Mar 24) to 3.45, marking a decrease of 3.29.
- For Earning Retention Ratio (%), as of Mar 25, the value is 95.84. This value exceeds the healthy maximum of 70. It has increased from 91.33 (Mar 24) to 95.84, marking an increase of 4.51.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 96.55. This value exceeds the healthy maximum of 70. It has increased from 93.26 (Mar 24) to 96.55, marking an increase of 3.29.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 33.25. This value is within the healthy range. It has increased from 15.80 (Mar 24) to 33.25, marking an increase of 17.45.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 21.61. This value is within the healthy range. It has increased from 10.37 (Mar 24) to 21.61, marking an increase of 11.24.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,764.96. It has increased from 1,468.53 (Mar 24) to 1,764.96, marking an increase of 296.43.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1. It has increased from 0.74 (Mar 24) to 0.88, marking an increase of 0.14.
- For EV / EBITDA (X), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 8.54 (Mar 24) to 7.73, marking a decrease of 0.81.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 24) to 0.86, marking an increase of 0.13.
- For Retention Ratios (%), as of Mar 25, the value is 95.83. This value exceeds the healthy maximum of 70. It has increased from 91.32 (Mar 24) to 95.83, marking an increase of 4.51.
- For Price / BV (X), as of Mar 25, the value is 1.59. This value is within the healthy range. It has increased from 1.43 (Mar 24) to 1.59, marking an increase of 0.16.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 24) to 0.86, marking an increase of 0.13.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.07 (Mar 24) to 0.08, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Insecticides India Ltd:
- Net Profit Margin: 7.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.76% (Industry Average ROCE: 15.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.09% (Industry Average ROE: 19.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 21.61
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.69
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.6 (Industry average Stock P/E: 31.52)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.09
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.07%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | 401-402, Lusa Tower, Delhi Delhi 110033 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Hari Chand Aggarwal | Chairman & Wholetime Director |
| Mr. Rajesh Kumar Aggarwal | Managing Director |
| Mr. Nikunj Aggarwal | Whole Time Director |
| Mr. Anil Kumar Goyal | Whole Time Director |
| Ms. Praveen Gupta | Independent Director |
| Mr. Anil Kumar Bhatia | Independent Director |
| Mr. Shyam Lal Bansal | Independent Director |
| Mr. Supratim Bandyopadhay | Independent Director |
FAQ
What is the intrinsic value of Insecticides India Ltd?
Insecticides India Ltd's intrinsic value (as of 03 January 2026) is ₹640.25 which is 9.82% lower the current market price of ₹710.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,067 Cr. market cap, FY2025-2026 high/low of ₹1,098/532, reserves of ₹1,167 Cr, and liabilities of ₹1,973 Cr.
What is the Market Cap of Insecticides India Ltd?
The Market Cap of Insecticides India Ltd is 2,067 Cr..
What is the current Stock Price of Insecticides India Ltd as on 03 January 2026?
The current stock price of Insecticides India Ltd as on 03 January 2026 is ₹710.
What is the High / Low of Insecticides India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Insecticides India Ltd stocks is ₹1,098/532.
What is the Stock P/E of Insecticides India Ltd?
The Stock P/E of Insecticides India Ltd is 14.6.
What is the Book Value of Insecticides India Ltd?
The Book Value of Insecticides India Ltd is 411.
What is the Dividend Yield of Insecticides India Ltd?
The Dividend Yield of Insecticides India Ltd is 0.28 %.
What is the ROCE of Insecticides India Ltd?
The ROCE of Insecticides India Ltd is 17.2 %.
What is the ROE of Insecticides India Ltd?
The ROE of Insecticides India Ltd is 13.3 %.
What is the Face Value of Insecticides India Ltd?
The Face Value of Insecticides India Ltd is 10.0.